Trilaciclib induces immune changes within the tumor microenvironment in early-stage triplenegative breast cancer

Category Primary study
JournalCancer Research
Year 2023
This article has no abstract
Epistemonikos ID: 6c61f7b56268a5c2e446f5ab47b8016d03a28c08
First added on: Feb 15, 2025